Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
"The Circulating Tumor Cell (CTC) market registered US$ 5.395 Bn in 2019 and it is estimated to reach more than US$ 15.449 Bn by 2028, likely to grow with a CAGR of 12.4 % during the forecast period."
The opportunities in the circulating tumor cell (CTC) market are propelling with the exception rate against the fear of the rapidly growing prevalence of cancer. The use of circulating tumor cells (CTC) as a tool for personalized medicine in next-generation cancer therapy is gaining popularity worldwide. Currently, the enumeration Circulating tumor cells are emerging as one of the most reliable extrapolative indicators for breast, colorectal, and prostate cancer. They provide tremendous potential in both detection and treatment at the early stage of cancer.
Promptly Growing Prevalence of Cancer All Over the World to Ensure the Rapid Growth for The Circulating Tumor Cell Market
According to the World Health Organization (WHO) “cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018”. The occurrence of these groups of diseases is majorly affecting the population with the different age groups worldwide. This further anticipated to lead rise in mortality. In the United States, approximately 550,000 women are being affected by cervical cancer across the world that represents almost 8% of the entire female cancer. More than 90% of the death cases from cervical cancer were documented from the lower-income countries. Accordingly, several organizations are more focusing on the introduction of new and effective companion diagnostics and preventive medicine in the cancer treatment that propelling the growth of the circulating tumor cell (CTC) market.
Advantages of Circulating Tumor Cell (CTC) Over the Other Oncological Clinical Practice Are Anticipated To Drive the Market Growth
The acceptance of new and effective oncology practices such as circulating tumor cells (CTC) are remarkably providing treatment effectiveness, metastatic risk and disease progression of cancer. The research shows circulating tumor cell (CTC) plays an important role in early cancer diagnosis and prognosis. It is an effective predictor in the different cancer types including breast, lung and many other cancers. The CTC also offers real-time assessment in cancer development with the long term disease monitoring. The acceptance of different oncological practices in the cancer treatments is likely to offer multiple opportunities in the circulating tumor cell (CTC) market in the near future. Furthermore, the diagnosis and the treatment rate are also a vital factor in the growth of the circulating tumor cell (CTC) market. Moreover, the introduction of cluster chip technology in cancer management and Prospective applications of CTC are favoring the market growth.
Ongoing Research and Developments in the Cancer Treatment to Open Doors to Multiple Opportunities
The cancer diagnosis and treatment keep on seeing incessant changes that have a positive impact on the prevention of cancer. The several organizations and the key players are focusing to develop the more effective, easier and cheaper tests that provide operative information in cancer detection. the growing introduction of the CTC enrich products in the oncology research are likely to propel the market growth over the forecast period. The ongoing research and the development activities in this field are projected to expand the reliability, test effectiveness, and accuracy in the cancer diagnostics. Thus, this is likely to accelerate the growth of the circulating tumor cell (CTC) market in the upcoming years. On the other hand, the high preference for point-of-care testing is expected to hamper the market growth.
CTC Enrichment Methods to Dominate the Growth of Circulating Tumor Cell Market
Among these technologies, CTC enrichment methods hold the maximum market share in the Circulating tumor cell (CTC) market. This CTC enrichment method consists of various types of methods including In vivo positive selection, Ex vivo positive selection, Single spiral microchannel, Microchips, Negative selection, and many others. The growing demand for CTC enrichment methods is majorly propelling the growth of the circulating tumor cell market.
On the basis of Application, the circulating tumor cell market is classified into EMT biomarkers development, Cancer stem cell research, Tumorgenesis research, and Other Applications. growing investments in the R&D activities are majorly contributing to the growing demand for CTC products in various applications.
The key players in the eye drops and lubricants market include Fluxion Biosciences, Clearbridge BioMedics, Cynvenio Biosystems, Advanced Cell Diagnostics, Biocep Ltd., Apocell, Aviva Biosciences, Greiner Bio-one GmbH, Creatv Microtech, Inc., Vitatex, Epic Biosciences, Janssen Diagnostics, Miltenyi Biotech. These players are majorly engaged with the research and development, mergers, and collaboration activities to improve their operating margins and product portfolio. For instance, In January 2020, Celsee, Inc. and Kindstar Global announced a purchase agreement to provide scientists at the Kindstar Laboratory System in China with Celsee’s Genesis System. This agreement is for the research of monitoring circulating tumor cells (CTCs) in lung, breast, and bladder cancers.
- CTC detection methods
- Molecular (RNA) based technologies
- Immunocytochemical technologies
- Xenotransplantation models
- CTC enrichment methods
- CTC analysis
- EMT biomarkers development
- Cancer stem cell research
- Tumorgenesis research
- North America
- Asia Pacific
- Latin America
- Middle East & Africa